Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein

Journal of Vascular Surgery

Volumn 28, Issue 4, 1998, Pages 695-701

  Porter, K E ^a   Olojugba, D H ^a   Masood, I ^a   Pemberton, M ^a   Bell, P R F ^a   London, N J M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; ORGAN CULTURE; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

EID: 0031755457     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(98)70096-5     Document Type: Article

References (47)

1. K Varty KE Allen PRF Bell NJM London Infrainguinal vein graft stenosis Br J Surg 80 1993 825 833
2. J Van der Meer HL Hillege WH van Gilst AB de la Rivière PHJM Dunselman V Fidler A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery: no difference in 1 year occlusion rates and clinical outcome Circulation 90 1994 2367 2374
3. RM Eloakley ARJ Cale JE Wright Use of internal mammary artery for coronary artery bypass grafts in the United Kingdom Ann Thorac Surg 59 1995 794
4. GJ Cooper MJ Underwood PB Deverall Arterial and venous conduits for coronary artery bypass—a current review Eur J Cardiothorac Surg 10 1996 129 140
5. M Yanagisawa H Kurihara S Kimura M Tomobe M Kobayashi Y Mitsui A novel potent vasoconstrictor pepide produced by vascular endothelial cells Nature 332 1988 411 415
6. A Bobik A Grooms JA Millar S Grinpukel Growth factor activity of endothelin on vascular smooth muscle Am J Physiol 258 1990 C408 C415
7. Y Hirata Y Takagi Y Fukuda F Marumo Endothelin is a potent mitogen for rat vascular smooth muscle cells Atherosclerosis 78 1989 225 228
8. I Komuro H Kurihara T Sugiyama F Takaku Y Yazaki Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells FEBS Lett 238 1988 249 252
9. I Masood KE Porter NJM London Endothelin-1 is a mediator of intimal hyperplasia in an organ culture of human saphenous vein Br J Surg 84 1997 499 503
10. I Masood KE Porter NJM London JH Pringle Endothelin-1 expression in vein graft stenosis J Vasc Surg 24 1996 901 902
11. S Ravalli M Szabolcs A Albala R Michler PJ Cannon Increased immunoreactive endothelin-1 in human transplant coronary artery disease Circulation 94 1996 2096 2102
12. OF Wagner G Christ J Wojta H Vierhapper S Parzer PJ Nowotny Polar secretion of endothelin-1 by cultured endothelial cells J Biol Chem 267 1992 16066 16068
13. H Arai S Hori I Aramori H Ohkubo S Nakanishi Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 1990 730 732
14. T Sakurai M Yanagisawa Y Takuwa H Miyazaki S Kimura K Goto Cloning of a cDNA encoding a non isopeptide selective subtype of the endothelin receptor Nature 348 1990 732 735
15. B receptors mediate contraction to endothelin-1 in human blood vessels Circulation 89 1994 1203 1208
16. A subtype Br J Pharmacol 114 1995 1110 1116
17. PH Dagassan V Breu M Clozel A Kunzli P Vogt M Turina Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries J Cardiovasc Pharmacol 22 1996 147 153
18. SA Douglas C Louden LM Vickeryclark BL Storer T Hart GZ Feuerstein A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty—protective effects of the novel nonpeptide endothelin receptor antagonist SB-209670 Circ Res 75 1994 190 197
19. SM Kanse K Takahashi JB Warren T Perera M Porta M Ghatei Production of endothelin by vascular smooth muscle cells J Cardiovasc Pharmacol 17 Suppl 7 1991 S113 S116
20. C Serradiel-Le Gal JM Herbert C Garcia M Boutin JP Maffrand Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic pathway of endothelin Peptides 12 1991 575 579
21. S Eguchi Y Hirata T Imai K Kanno F Marumo Phenotypic change of endothelin receptor subtype in cultured vascular smooth muscle cells Endocrinology 134 1994 222 228
22. H Azuma H Hamasaki Y Niimi T Terada O Matsubara Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries Am J Physiol 36 1994 H2259 H2267
23. SA Douglas EH Ohlstein Endothelin-1 promotes neointima formation after balloon angioplasty in the rat J Cardiovasc Pharmacol 22 Suppl 8 1993 S371 S373
24. P Ferrer M Valentine Y Jenkins-West H Weber NL Goller SK Durham Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries J Cardiovasc Pharmacol 26 1995 908 915
25. Y Takiguchi K Sogabe The selective endothelin ET(A) receptor antagonist FR139317 inhibits neointimal thickening in the rat Eur J Pharmacol 309 1996 59 62
26. SA Douglas LM Vickeryclark C Louden EH Ohlstein Selective ET(A) receptor antagonism with BQ-123 is insufficient to inhibit angioplasty-induced neointima formation in the rat Cardiovasc Res 29 1995 641 646
27. M Ferrell V Fuster HK Gold JH Chesbro Choosing appropriate experimental animal models for the prevention of restenosis Circulation 85 1992 1630 1631
28. M Clozel V Breu GA Gray B Kalina BM Loffler K Burri Pharmacological characterisation of Bosentan, a new potent orally active nonpeptide endothelin receptor antagonist J Pharmacol Exp Ther 270 1994 228 235
29. A receptor. Proceedings of the Twelfth American Peptide Symposium; 1991 Jun 16-21; Cambridge, Mass. p. 506.
30. K Ishikawa M Ihara K Noguchi T Mase K Fujita U Kumagai Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788 Proc Natl Acad Sci U S A 91 1994 4892 4896
31. KE Porter K Varty L Jones NJM London PRF Bell Human saphenous vein organ culture: a useful model of intimal hyperplasia? Eur J Vasc Endovasc Surg 11 1996 48 58
32. AA Soyombo GD Angelini AJ Bryan B Jasani AC Newby Intimal proliferation in an organ culture of human saphenous vein Am J Pathol 137 1990 1401 1410
33. AA Soyombo VJ Thurston AC Newby Endothelial control of vascular smooth muscle cell proliferation in an organ culture of human saphenous vein Eur Heart J 14 S1 1993 201 206
34. KE Allen K Varty L Jones RD Sayers PRF Bell NJM London Human venous endothelium can promote intimal hyperplasia in a paracrine manner J Vasc Surg 19 1994 577 584
35. K Varty L Jones KE Porter PRF Bell NJM London A quantitative study of long saphenous vein morphology in patients undergoing arterial surgery Phlebology 10 1995 90 93
36. RD Sayers L Jones K Varty K Allen JDT Morgan PRF Bell The histopathology of infrainguinal vein graft stenoses Eur J Vasc Surg 7 1993 16 20
37. RJ Miller An elastin stain Medical Laboratory Technology 28 1971 148 154
38. JPR Herrman WRM Hermans J Vos PW Serruys Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the holy grail? (Part 1) Drugs 46 1993 18 52
39. SM Franklin DP Faxon Pharmacological prevention of restenosis after coronary angioplasty: review of the randomized clinical trials Coron Artery Dis 4 1993 232 242
40. C Bauters T Meurice M Hamon E McFadden JM Lablanche ME Bertrand Mechanisms and prevention of restenosis: from experimental models to clinical practice Cardiovasc Res 31 1996 835 846
41. KE Porter S Nydahl P Dunlop K Varty AJ Thrush NJM London The development of an in vitro flow model of human saphenous vein intimal hyperplasia Cardiovasc Res 31 1996 607 614
42. K Varty KE Allen L Jones RD Sayers PRF Bell NJM London The influence of Losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein Br J Surg 81 1994 819 822
43. K Varty KE Allen RD Sayers L Jones DA Ratliff PRF Bell The influence of low molecular weight heparin on neointimal proliferation in cultured human saphenous vein Eur J Vasc Surg 8 1994 174 178
44. C Weber R Schmitt H Birnboeck G Hopfgartner SP Vanmarle PAM Peeters Pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist bosentan in healthy human subjects Clin Pharmacol Ther 60 1996 124 137
45. SA Douglas LM Vickery-Clark C Louden JD Elliott EH Ohlstein Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat—a comparison of selective ET(A) receptor antagonism and dual ET(A)/ET(B) receptor antagonism using BQ 123 and SB 204670 J Cardiovasc Pharmacol 26 1995 S186 S189
46. WG Haynes CE Ferro DJ Webb Physiological role of endothelin in maintenance of vascular tone in humans J Cardiovasc Pharmacol 26 1995 S183 S185
47. FG Spinale JD Walker R Mukherjee JP Iannini AT Keever KP Gallagher Concomitant endothelin subtype A blockade during the progression of pacing-induced congestive heart failure in rabbits—beneficial effects on left ventricular and myocyte function Circulation 95 1997 1918 1929